CME Group (NASDAQ:CME) Given New $228.00 Price Target at Barclays

CME Group (NASDAQ:CME) had its target price lifted by Barclays from $226.00 to $228.00 in a report issued on Thursday, Benzinga reports. The brokerage currently has an equal weight rating on the financial services provider’s stock.

Several other research analysts also recently weighed in on CME. Keefe, Bruyette & Woods upped their target price on shares of CME Group from $222.00 to $226.00 and gave the company a market perform rating in a research note on Thursday. Bank of America upped their target price on shares of CME Group from $209.00 to $216.00 and gave the company a neutral rating in a research note on Thursday. Morgan Stanley increased their price objective on shares of CME Group from $222.00 to $225.00 and gave the company an equal weight rating in a research note on Tuesday, April 9th. Rosenblatt Securities reiterated a sell rating and set a $187.00 price objective (up from $185.00) on shares of CME Group in a research note on Thursday. Finally, Deutsche Bank Aktiengesellschaft reiterated a hold rating and set a $210.00 price objective (down from $235.00) on shares of CME Group in a research note on Friday, April 5th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, CME Group currently has an average rating of Hold and an average price target of $217.80.

CME Group Price Performance

CME opened at $212.54 on Thursday. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. CME Group has a 52-week low of $175.73 and a 52-week high of $223.80. The company has a 50 day moving average of $214.76 and a two-hundred day moving average of $211.93. The company has a market cap of $76.51 billion, a P/E ratio of 24.18, a P/E/G ratio of 5.97 and a beta of 0.49.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.44 by $0.06. CME Group had a net margin of 56.84% and a return on equity of 12.45%. The company had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.48 billion. During the same period in the previous year, the firm earned $2.42 earnings per share. CME Group’s revenue for the quarter was up 3.2% on a year-over-year basis. On average, analysts expect that CME Group will post 9.58 earnings per share for the current year.

CME Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 26th. Shareholders of record on Friday, March 8th were given a $1.15 dividend. This is a boost from CME Group’s previous quarterly dividend of $1.10. The ex-dividend date was Thursday, March 7th. This represents a $4.60 annualized dividend and a yield of 2.16%. CME Group’s dividend payout ratio is 52.33%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of CME. AE Wealth Management LLC grew its position in CME Group by 25.5% in the 3rd quarter. AE Wealth Management LLC now owns 2,543 shares of the financial services provider’s stock worth $509,000 after purchasing an additional 516 shares during the last quarter. Private Trust Co. NA grew its position in CME Group by 14.9% in the 3rd quarter. Private Trust Co. NA now owns 3,147 shares of the financial services provider’s stock worth $630,000 after purchasing an additional 408 shares during the last quarter. Koshinski Asset Management Inc. bought a new position in shares of CME Group in the third quarter valued at approximately $298,000. CX Institutional boosted its holdings in shares of CME Group by 590.1% in the third quarter. CX Institutional now owns 14,810 shares of the financial services provider’s stock valued at $2,965,000 after acquiring an additional 12,664 shares in the last quarter. Finally, Oak Thistle LLC bought a new position in shares of CME Group in the third quarter valued at approximately $462,000. Institutional investors own 87.75% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.